Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 284 results for "Cgix"

Cancer Genetics, Inc. Announces a Global Partnership with BARC Global Central Laboratory to Offer Comprehensiv...
TeleTrader.com

CANCER GENETICS : Announces $5.5 Million Registered Direct Off...

RUTHERFORD, N.J., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ('Cancer Genetics' or the 'Company'), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that it ... 4 Traders, 23 hours ago
[x]  
Octafinance

Rodman & Renshaw Prescribe A $6 Price Target For Cancer Genetics

Cancer Genetics Inc (NASDAQ: CGIX ) represents a highly differentiated investment opportunity, given its broad pipeline of tests…and with its ability to generate high-margin revenue from partnerships with biopharmaceutical firms that are seeking ...
 Benzinga.com2 days ago Rodman & Renshaw Starts Cancer Genetics (NYSE:CGIX) Coverage With Buy Rating and $6.00 Target Price per Share  Octafinance1 day ago Rodman & Renshaw Has Initiated Coverage on Cancer Genetics (NASDAQ:CGIX) with Buy and with $6.0 Target  Octafinance2 days ago
American Banking News

Equities Research Analysts New Coverage for September, 27th (BC, CGIX, CLST, CLSU, CYBG, EFII, ERII, HTZ, MITL, NVZMY)

Equities Research Analysts new coverage for Tuesday, September 27th: Imperial Capital began coverage on shares of Brunswick Corp. (NYSE:BC) HC Wainwright initiated coverage on shares of Cancer Genetics (NASDAQ:CGIX) This story is the sole ...
 American Banking News1 day ago Cancer Genetics Inc. (CGIX) Coverage Initiated by Analysts at Rodman & Renshaw  American Banking News2 days ago Cancer Genetics Inc. (CGIX) Now Covered by Rodman & Renshaw  WKRB News3 hours ago Cancer Genetics Inc. (CGIX) Receives New Coverage from Analysts at HC Wainwright  American Banking News1 day ago
[x]  

Cancer Genetics' (CGIX) CEO Panna Sharma on Q2 2016 Results - Earnings Call Transcript

Cancer Genetics Incorporated (NASDAQ: CGIX ) Q2 2016 Earnings Conference Call August 10, 2016 08:30 AM ET Executive Edward Sitar - CFO Panna Sharma - President and CEO Jay Roberts - COO Analyst Ben Haynor - Feltl and Company ...
 Seeking Alpha1 month ago Margins Are Key For NeoGenomics In Q2 2016  Seeking Alpha2 months ago

Cancer Genetics beats by $0.05, beats on revenue

ews Editor Cancer Genetics (NASDAQ:CGIX): Q2 EPS of -$0.28 beats by $0.05. Revenue of $7M (+67.5% Y/Y) beats
 Seeking Alpha1 month ago

Cancer Genetics: 'Warrant,' You Are Under Arrest

Introduction I penned two articles over the past couple of months, claiming that Cancer Genetics, Inc. (NASDAQ: CGIX ) was running out of money and going to need capital soon. As it turns out, I was correct. On May 25, 2016, CGI issued a direct ...
 Seeking Alpha2 months ago
Nasdaq

Healthcare Stocks' Q2 Earnings on Aug 10: QHC, CDNA & CGIX

Medical is one of the 10 sectors in the S&P 500 cohort that is expected to witness earnings growth in the second quarter. The sector's earnings are likely to increase 4.4% on a revenue hike of 7.7%. We note that 433 S&P companies have already ...
 Yahoo! Singapore1 month ago
[x]  
American Banking News

Analysts New Coverage for September, 26th (AIMT, ALDX, AMSG, AMTD, ARIA, ASND, AYTU, CGIX, DBVT, DHT)

Analysts new coverage for Monday, September 26th: JMP Securities initiated coverage on shares of Aimmune Therapeutics (NASDAQ:AIMT) HC Wainwright assumed coverage on shares of Aldeyra Therapeutics (NASDAQ:ALDX) This story is the sole property ...
 American Banking News2 days ago

Zacks: Cancer Genetics Inc. (NASDAQ:CGIX) Receives Consensus Recommendation of Strong Buy from Analysts

Shares of Cancer Genetics Inc. (NASDAQ:CGIX) have been given an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the ...
 SleekMoney4 weeks ago Zacks: Analysts Set $5.75 Target Price for Cancer Genetics Inc. (NASDAQ:CGIX)  Ticker Report1 month ago
[x]  
SleekMoney

Stock Analysts Downgrades for July, 29th (ACFC, ACHI, ACW, ALDR, ANSS, ATHX, AUDC, AVAV, BHLB, CGIX)

Stock Analysts downgrades for Friday, July 29th: Atlantic Coast Financial Corp. (NASDAQ:ACFC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, Atlantic Coast Financial Corporation, ...
 SleekMoney1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less